Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Noela Owarwo"'
Publikováno v:
AIDS Research and Therapy, Vol 20, Iss 1, Pp 1-6 (2023)
Abstract Objective HIV infection increases the risk of type 2 diabetes and may influence its phenotypic profile. In this study, we aimed to compare the anthropometric and metabolic characteristics of HIV-infected and uninfected adult Ugandans with ne
Externí odkaz:
https://doaj.org/article/f39f0682bd8f45ffbd8253d77178a097
Autor:
Adelline Twimukye, Miriam Laker, Eva Agnes Laker Odongpiny, Florence Ajok, Henry Onen, Ivan Kalule, Phoebe Kajubi, Kay Seden, Noela Owarwo, Agnes Kiragga, Mari Armstrong-Hough, Anne Katahoire, Andrew Mujugira, Mohammed Lamorde, Barbara Castelnuovo
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background In 2019, the World Health Organisation (WHO) recommended Dolutegravir (DTG) as the preferred first-line antiretroviral treatment (ART) for all persons with HIV. ART regimen switches may affect HIV treatment adherence. We sought to
Externí odkaz:
https://doaj.org/article/4e44c82667bb4af7ad5d72f67e6e462a
Autor:
Andrew Mujugira, Agnes N. Kiragga, Anne Katahoire, Mohammed Lamorde, Miriam Laker, Henry Onen, Mari Armstrong-Hough, Noela Owarwo, Florence Ajok, Kay Seden, Barbara Castelnuovo, Adelline Twimukye, Eva Agnes Laker Odongpiny, Ivan Kalule, Phoebe Kajubi
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background In 2019, the World Health Organisation (WHO) recommended Dolutegravir (DTG) as the preferred first-line antiretroviral treatment (ART) for all persons with HIV. ART regimen switches may affect HIV treatment adherence. We sought to describe
Autor:
Rachel Musomba, Mohammed Lamorde, Kay Seden, Barbara Castelnuovo, Godwin Anguzu, Benson Nasasira, Arnold Arinaitwe, Annet Onzia, Isaac Lwanga, Eva Laker, Agnes N. Kiragga, Abdullah Wailagala, Noela Owarwo, Ivan Kalule
Publikováno v:
Drug Safety. 43:1133-1140
INTRODUCTION AND OBJECTIVE: In May 2018, the World Health Organization and other regulatory authorities released a safety alert for dolutegravir related to a risk of neural tube defects among women exposed to dolutegravir at the time of conception. M
Autor:
Angella Kigongo Nabakooza, Sharon Kitibwakye Nakamanya, Eva Laker, Elizabeth Katana, Noela Owarwo, Isaac Lwanga, Barbara Castelnuovo, Mohammed Lamorde, Freddy Eric Kitutu
BackgroundBoosted atazanavir (ATV/r)-based Antiretroviral Therapy (ART) regimen is recommended by the World Health Organization (WHO) as second line treatment for HIV/AIDS. ATV/r is known to cause clinical jaundice, which may lead to non-adherence to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::954b7b71fff9cc814aedd156c1ab8a44
https://doi.org/10.21203/rs.3.rs-1405649/v1
https://doi.org/10.21203/rs.3.rs-1405649/v1
Autor:
Dathan Mirembe Byonanebye, Maria S Nabaggala, Agnes Bwanika Naggirinya, Mohammed Lamorde, Elizabeth Oseku, Rachel King, Noela Owarwo, Eva Laker, Richard Orama, Barbara Castelnuovo, Agnes Kiragga, Rosalind Parkes-Ratanshi
BACKGROUND Following the successful scale-up of antiretroviral therapy (ART), the focus is now on ensuring good quality of life (QoL) and sustained viral suppression in people living with HIV. The access to mobile technology in the most burdened coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fe6d474c57bc4bf11967b6e0ea073ce
https://doi.org/10.2196/preprints.22229
https://doi.org/10.2196/preprints.22229
Autor:
Solome Naluwu, Winnie Nakiyingi, Barbara Castelnuovo, Rosalind Ratanshi, Jane Namukasa Wanyama, Noela Owarwo, Madina Seera, sarah Maria Nabaggala, Agnes N. Kiragga
Whilst there is increasing interest in the use of mobile phones and other technology (mHealth) for improving health outcomes; limited data exists on how young people living with HIV use mhealth technologies to get information and to support their hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83daec1b3021d1049daf7e496d03c215
https://www.repository.cam.ac.uk/handle/1810/275835
https://www.repository.cam.ac.uk/handle/1810/275835
Autor:
Kibirige, Davis1,2 (AUTHOR) kibirigedavis@gmail.com, Owarwo, Noela3 (AUTHOR), Kyazze, Andrew Peter4 (AUTHOR), Morgan, Bethan5 (AUTHOR), Olum, Ronald6 (AUTHOR) kibirigedavis@gmail.com, Bongomin, Felix7 (AUTHOR), Andia-Biraro, Irene4 (AUTHOR)
Publikováno v:
Open Forum Infectious Diseases. Apr2024, Vol. 11 Issue 4, p1-15. 15p.
Autor:
Kibirige, Davis1,2 (AUTHOR) kibirigedavis@gmail.com, Sekitoleko, Isaac2 (AUTHOR), Owarwo, Noela3 (AUTHOR), Andia-Biraro, Irene4 (AUTHOR), Lumu, William5 (AUTHOR)
Publikováno v:
AIDS Research & Therapy. 8/18/2023, Vol. 20 Issue 1, p1-6. 6p.
Autor:
Fritz, Cristin Q.1 cristin.fritz@vanderbilt.edu, Blevins, Meridith2,3, Lindegren, Mary Lou1,3,4, Wools-Kaloutsian, Kara5, Musick, Beverly S.6, Cornell, Morna7, Goodwin, Kelly8, Addison, Dianne9, Dusingize, Jean Claude10, Messou, Eugène11, Poda, Armel12, Duda, Stephany N.13, McGowan, Catherine C.14, Law, Matthew G.15, Moore, Richard D.16, Freeman, Aimee17, Nash, Denis9, Wester, C. William3,14
Publikováno v:
Journal of the International AIDS Society. Jan2017, Vol. 20, p1-14. 14p. 10 Charts.